Background-Cardioplegia and cardiopulmonary bypass (CP/CPB) subjects myocardium to complex injurious stimuli that can result in cardiomyocyte and vascular contractile abnormalities. Rottlerin, originally identified as a delta-protein kinase C inhibitor, has a number of known additional effects that may be beneficial in the setting of CP/CPB. We tested the hypothesis that rottlerin mitigates deleterious effects associated with CP/CPB. Methods and Results-Langendorff-perfused isolated rat hearts were subjected to 2 hours intermittent cold (10°C) CP (St Thomas II) followed by 30 minutes normothermic reperfusion. CP was delivered every 30 minutes for 1 minute. Hearts were treated with rottlerin 1 mol/L (CPϩR) (nϭ7) or without rottlerin (CP) (nϭ9), and the BK Caϩϩ channel inhibitor paxilline 100 nmol/L was supplied in the CP. Hearts constantly perfused with KHB served as controls (nϭ6). Baseline parameters of cardiac function were similar between groups. CP resulted in reduced cardiac function (left ventricular diastolic pressure, 39Ϯ3.8%; ϮdP/dt, 32Ϯ4.4%, Ϫ41Ϯ5.1% decrease compared to baseline). Treatment with rottlerin 1 mol/L significantly improved CP-induced cardiac function (left ventricular diastolic pressure, 20Ϯ5.9%; ϮdP/dt, 5.2Ϯ4.5%, Ϫ11.6Ϯ4.7% decrease versus baseline; PϽ0.05 CPϩR versus CP). Rottlerin also caused a significant increase in coronary flow postreperfusion (CP, 34Ϯ4.2% decrease from baseline; CPϩR, 26Ϯ9.6% increase over baseline; Pϭ0.01). Independent of vascular effects, CP significantly decreased isolated myocyte contraction, which was restored by rottlerin treatment. The BK Caϩϩ channel inhibitor greatly reduced the majority of beneficial effects associated with rottlerin.
C ardiac surgery using cardioplegia (CP) and cardiopulmonary bypass subjects myocardium to hypothermic reversible ischemic injury that can impair cardiac function (aka, myocardial stunning). The main protective benefits of CP are mediated through myocardial hypothermia and diastolic arrest, which preserve myocardial energy reserves. The ischemic insults associated with CP arrest during surgery include myocyte hypoxia, acidosis, oxidant-dependent damage, metabolic and structural alterations, and reduced cardiac function. [1] [2] [3] [4] In addition to direct effects on cardiomyocytes, CP can result in marked coronary vascular complications, including impaired vasodilation, propensity for spasm, and overall decreased perfusion. 5 Although contractile impairment in the majority of patients resolves quickly, Ϸ10% can develop a cardiac low-output syndrome attributable in part to depressed left ventricular (LV) or atrial contractile function. Consequently, low-output syndrome prolongs recovery times and significantly elevates risk of mortality. 6 Furthermore, the need for enhanced cardioprotection is required for specific high-risk patient populations (eg, prolonged surgical times, low ejection fraction, older age).
Rottlerin has been reported as a protein kinase C-␦ (PKC␦) inhibitor. PKC␦ has been implicated in depressed cardiac function and cell death after ischemia-reperfusion injury as well as in promoting vascular smooth muscle contraction. [7] [8] [9] However, rottlerin as a true inhibitor of PKC␦ has been called into question and has generated considerable controversy. 10, 11 Other PKC␦-independent effects of rottlerin recently have been recognized. Rottlerin has been reported as a potent large conductance potassium channel (BK Caϩϩ ) opener. 12 Opening of BK Caϩϩ channels is beneficial for postischemic alterations in vasomotor activity. 13 In addition, other BK Caϩϩ channel openers are reported to limit ischemia-related mitochondrial Ca 2ϩ overload. 14, 15 . Finally, rottlerin is capable of reducing oxygen radical formation. 10 All these mechanisms of injury occur during CP arrest and reperfusion. Therefore, through a combination of targets, rottlerin may block many of the deleterious side effects associated with CP arrest that limit both vascular and cardiomyocyte function.
Methods

Isolated Langendorff-Perfused Model of CP Arrest
Male Sprague-Dawley rats (Charles River; Wilmington, MA) were anesthetized with 80 mg/kg ketamine IP and 5 mg/kg xylazine IP and anticoagulated with heparin (2000 U/kg IV), and the heart was rapidly exposed. The aorta was immediately cannulated and retrograde perfused in Langendorff mode with a water jacketed organ chamber and perfusion system (IH-SR; Harvard Apparatus, Inc; Holliston, MA). After cannulation, the heart was cleaned of excess tissue and vessels, the left atrium removed, and a balloon placed in the LV. LV end-diastolic pressure was set to Ϸ8 mm Hg at the beginning of the experiment. A temperature probe placed in the pulmonary artery monitored myocardial temperature. The hearts were perfused in constant pressure mode (Ϸ70 mm Hg) with a modified KHB (NaCl, 118 mmol/L; KCl, 4.7 mmol/L; CaCl 2 , 1.25 mmol/L; MgSO 4 , 1.66 mmol/L; NaHCO 3 , 24.88 mmol/L; KH 2 PO 4 , 1.18 mmol/L; Na-pyruvate, 2.0 mmol/L) for 30 minutes to stabilize and record baseline measurements. During baseline measurements, myocardial temperature was maintained at 37°C. Groups subjected to cold crystalloid CP solution were perfused with St Thomas II solution (NaCl, 110 mmol/L; KCl, 16 mmol/L; MgCl 2 , 110 mmol/L; CaCl 2 , 1.5 mmol/L; NaHCO 3 , 10 mmol/L). Myocardial cooling during CP was initiated at the onset of CP infusion through rapidly switching the Langendorff organ chamber and perfusate to a refrigerated circulator. Myocardial temperature was maintained at 10°C for the duration of CP. CP groups were perfused initially for 2 minutes followed by a 1-minute infusion at 30, 60, and 90 minutes arrest, respectively. After 120 minutes, the organ chamber and perfusate were switched back to a heating circulator and the heart perfused at 70 mm Hg with modified KHB. Myocardial temperature was subsequently maintained at 37°C. Indices of ventricular function, perfusion pressure, myocardial temperature, and organ chamber temperature were measured continuously throughout the experiment using an LDS-Ponemah data acquisition system. At the conclusion of the experiment, the heart was removed from the perfusion apparatus, and a small midtransverse slice was removed and immediately placed in 10% formalin for confocal microscopy. A second section was taken for a heart wet/dry weight ratio. Samples were weighed directly after procurement and after desiccation for 24 hours at 50°C. The remainder of the tissue was immediately placed in liquid N 2 .
SDS-PAGE and Immunoblot
SDS-PAGE and immunoblot were performed using standard methodology as previously described. 16 Antibodies for immunoblot were as follows: phosphospecific or total PKC␦, cardiac troponin I (cTNI), Akt, 3-phosphoinositide-dependent kinase 1 (PDK1), phosphatase and tensin homolog (PTEN), and extracellular signal-regulated kinase (ERK) from Cell Signaling (Beverly, MA); phospholamban (PLN) from Millipore (Billerica, MA); and phospho-and total heat shock protein 27 (HSP27) and ␣B-crystallin antibodies from Stressgen (Vancouver, BC).
Culture and Purification of Adult Rat Cardiomyocytes
Adult rat cardiomyocyte cultures were obtained from hearts according to a previously published protocol with modifications. 17 Briefly, hearts were excised from anesthetized adult rats, the aorta cannulated, and hearts perfused with 0.3% collagenase solution in perfusion buffer consisting of MEM (Joklik modification) supplemented with creatine, BDM, taurine, and insulin for 45 minutes. After perfusion, ventricles were removed and minced in the Ca 2ϩ -free collagenase solution for 3 to 5 minutes. Chunks then were incubated in 10 mL of perfusion buffer supplemented with BSA and 0.3 mmol/L CaCl 2 . Cells were washed in collagenase-free perfusion buffer 3 times with centrifugation. Myocytes were resuspended in DMEM culture medium supplemented with creatine, carnitine, taurine, penicillin/streptomycin, and insulin. Myocytes were plated at a density of 2ϫ10 4 cells/cm 2 on 10 g/mL laminin-coated dishes for length measurements the following day.
In Vitro CP and Myocyte Length Recordings
Cultured rat myocytes were switched to crystalloid CP solution bubbled with 5% CO 2 /95% N 2 under anoxic conditions. Cells then were placed in a hypoxia chamber evacuated with 5% CO 2 /95% N 2 for the indicated times and retained at 4°C. For simulated reperfusion, CP-treated cells were removed from the hypoxic chamber and returned to the cell culture incubator, and CP solution was replaced with a modified KHB containing NaCl, 118 mmol/L; KCl, 4.7 mmol/L; CaCl 2 , 1.25 mmol/L; MgSO 4 , 1.2 mmol/L; KH 2 PO 4 , 1.2 mmol/L; NaHCO 3 , 25 mmol/L; HEPES, 10 mmol/L; and glucose, 10 mmol/L. Control cells were maintained in a standard cell culture incubator for the duration of CP and switched to 37°C KHB at the time of simulated reperfusion. For length measurement, cells were moved to a heated stage with temperature-controlled perfusion and field stimulation capable of accepting 35-mm culture dishes (Harvard Apparatus). The cells were imaged with a CCD cameraequipped inverted microscope attached to a raster line video edge detector (Living Systems Instrumentation; Burlington, VT). Voltage signals were captured with a data acquisition unit attached to a computer running Ponemah physiology platform software. The recorded length data can be visualized in real time at 60 Hz by computer monitor and stored for subsequent analysis of percent length change and positive and negative first derivatives of LV pressure (ϮdP/dt). The video edge detector and data capture software were calibrated using voltage signals from a slide micrometer before each experiment. Only rod-shaped viable cells that responded appropriately to field stimulation were used.
Statistical Analysis
All statistical analyses were performed with Sigma Stat software (Systat Software Inc; Chicago, IL). For analysis of CP and CPϩrottlerin (CPϩR) functional time courses, 2-way repeatedmeasures ANOVA with Student Newman-Keuls post hoc analysis was performed. A 2-way ANOVA with Student Newman-Keuls was performed for isolated myocyte experiments. All other statistical tests were 1-way ANOVA with Student Newman-Keuls. PϽ0.05 determined significance.
Results
Rottlerin Alleviates CP-Induced Myocardial Stunning in the Isolated Heart
Cold crystalloid CP for 2 hours in the isolated rat hearts caused depressed cardiac contractile function on reperfusion. During CP, myocardial temperature was maintained at Ϸ10°C, followed by rewarming to 37°C during 30 minutes of reperfusion as described previously. 18 A representative experiment is presented in online-only Data Supplement Figure 1 . On reperfusion, there were significant reductions in systolic pressure, developed pressure, and ϮdP/dt compared with baseline ( Figure 1A through 1D ). Inclusion of rottlerin 1 mol/L in the CP solution significantly improved indices of cardiac function, including developed pressure ( Figure  1A) , ϮdP/dt ( Figure 1B and 1C) , and tau ( Figure 1D ).
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There were no significant changes in heart rate between groups ( Figure 1E ).
Rottlerin Improves CP-Induced Reductions in Coronary Perfusion
CP arrest and 30 minutes reperfusion reduced coronary flow compared with baseline. Hearts treated with rottlerin 1 mol/L in the CP solution showed significant improvements over CP alone (Figure 2A and 2B) . At 30 minutes of reperfusion, the CPϩR group showed a significant increase in flow over baseline, whereas CP and sham hearts showed overall reductions in flow ( Figure 2B ). There were no significant increases in wet/dry tissue weight ratios between groups, indicating no deleterious increases in tissue edema (online-only Data Supplement Figure 2 ).
Rottlerin Blocks CP-Impaired Myocyte Contractility In Vitro
To explore whether rottlerin alleviates CP-induced depressed contractile function solely through vascular effects, isolated rat cardiac myocytes were subjected to in vitro CP and simulated reperfusion with reoxygenation and rewarming. In vitro CP resulted in depressed myocyte contraction as determined by decreased myocyte length 
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shortening ( Figure 3A and 3B ). Inclusion of rottlerin 1 mol/L completely rescued CP-induced changes in myocyte length shortening ( Figure 3A and 4B) , indicating direct effects on cardiomyocytes.
Cardioprotective Effects of Rottlerin Are Independent of PKC␦
PKC␦ phosphorylation is known to correlate with increased PKC␦ activity. 19 However, CP did not increase the phosphorylation of PKC␦ on Y311, T505, or S643. There was an insignificant trend for CP-induced phosphorylation of PKC␦-T505, but treatment with rottlerin 1 mol/L did not attenuate this trend or decrease basal phosphorylation on any of the residues examined ( Figure 4A and 4B ). Phosphorylation of ERK and p38-mitogen-activated protein kinase (MAPK)/ HSP27 have been implicated as downstream of PKC␦ activation. 16, 20, 21 HSP27 is a downstream target of p38-MAPK that also may regulate contractile deficits associated with CP-induced stunning. 18, 22 Although CP induces phosphorylation of ERK and HSP27, these effects were independent of rottlerin ( Figure 4C and 4D ).
BK Ca؉؉ Channels Mediate Rottlerin-Induced Improvements in Post-CP Cardiac and Vascular Function
To determine whether rottlerin mediates its effects through the opening of BK Caϩϩ channels, hearts were treated with rottlerin 1 mol/L and the BK Caϩϩ channel blocker paxilline 100 nmol/L and 1 mol/L, both supplied in the CP condition. Paxilline blocked the majority of beneficial effects of rottlerin at 100 nmol/L and all the measured beneficial effects at 1 mol/L ( Figure 5 ). However, treatment with rottlerin and paxilline 1 mol/L caused significant increases in LV end-diastolic pressure and tau compared with CP treatment alone. Full-time courses of the paxilline-treated groups are presented in online-only Data Supplement Figure 3 .
Rottlerin Enhances CP-Induced Akt Phosphorylation Through BK Ca؉؉ Channels
CP caused significant phosphorylation increases in members of the Akt signaling cascade, including Akt ser473, Akt thr308, ser241 PDK1, and ser380 PTEN ( Figure 6 ). Compared with CP alone, rottlerin significantly increased the phosphorylation of Akt on thr308. All targets of the Akt pathway measured were significantly reduced in the rottlerin groups cotreated with paxilline 100 nmol/L ( Figure 6 ), indicating that this pathway is controlled by BK Caϩϩ channel modulation.
Rottlerin Does Not Reduce Protein or Lipid Oxidation
To determine whether rottlerin mediates its effects through antioxidant mechanisms, tissue protein and lipid oxidation were indirectly measured by carbonyl and malondialdehyde content, respectively. Neither CP nor addition of rottlerin significantly altered protein (online-only Data Supplement Figure 4A ) or lipid oxidation (online-only Data Supplement Figure 4B ) compared with sham treatment. 
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Rottlerin Does Not Alter PLN or cTnI Phosphorylation
Phosphorylation of PLN and cTnI are implicated in regulation of myocardial contractility. Neither CP nor CPϩR 1 mol/L changed basal levels of cTnI or PLN phosphorylation (online-only Data Supplement Figure 5 ).
Discussion
The principle findings of the current study indicate that rottlerin improves functional recovery of isolated hearts after cold CP arrest. As an additive to CP, rottlerin (1) increased isolated heart contractile performance, (2) enhanced significantly myocardial perfusion, and (3) directly increased contractile performance of cardiac myocytes independent of vascular effects. All of these beneficial effects appeared to be independent of PKC␦ activation as measured by phosphory-lation status and screening of potential downstream targets. In contrast, the beneficial effects of rottlerin were reduced by paxilline, implicating an important role for BK Caϩϩ channels. CP arrest can result in multiple complications after surgery, including enhanced coronary artery tone and decreased myocardial perfusion as well as perfusion-independent effects that cause myocardial stunning and contractile deficits. Rottlerin may mediate improvements in cardiomyocyte and smooth muscle function through known mechanisms of action that are independent of PKC␦.
First, rottlerin has been identified as an extremely potent BK Caϩϩ opener. 12 Activation of BK Caϩϩ channels results in coronary smooth muscle vasodilation. 13, 23 Further, activation of BK Caϩϩ channels with NS1619 (another BK channel activator) demonstrated improved vasodilation in vessels contracted with high K ϩ CP. 13 Inhibition of the BK Caϩϩ 
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Rottlerin Improves Cardioplegic Arrest S59 channels with paxilline greatly reduced the vasodilatory effect of rottlerin, indicating that rottlerin also works through smooth muscle BK Caϩϩ channels to improve coronary flow after CP. Second, rottlerin-induced activation of BK Caϩϩ channels may directly alleviate stunning of cardiac myocytes. Classical mechanisms of myocardial stunning associated with CP and cardiopulmonary bypass include the oxidant radical and Ca 2ϩ overload hypothesis. [2] [3] [4] 6, 24 The nonexclusive views propose (1) oxidant-dependent damage/oxidant-dependent activation of signaling, which negatively modulate the contractile apparatus, and (2) alterations in Ca 2ϩ homeostasis, which promote contractile abnormalities and metabolic alterations through mitochondrial damage. BK Caϩϩ channels reside in the cardiomyocyte inner mitochondrial membrane. 25 BK Caϩϩ channel activation is proposed to increase mitochondrial K ϩ accumulation, which, in turn, electrochemically limits mitochondrial Ca 2ϩ influx and reduces mitochondrial depolarization and permeability transition pore opening. 14, 15 Known cardioprotective effects associated with the BK Caϩϩ channel openers NS1619, NS11021, and DiCl-DHAA after ischemia-reperfusion injury include reductions in mitochondrial Ca 2ϩ overload, mitochondrial membrane depolarization, increased cell viability, and improved function in whole hearts. 15, 25, 26 Indeed, adaptation to hypoxia alone can partially activate the mitochondrial BK Caϩϩ channels, which is recognized as a protective response. 27, 28 In addition, we found that rottlerin treatment greatly enhanced the CP-induced phosphorylation of Akt on the required activation residue thr308. Akt activation is reported to be an upstream mediator of mitochondrial K ϩ channel function as well as a modulator of the mitochondrial depolarization and permeability transition pore. 29, 30 However, the present data indicate that Akt functions downstream of rottlerin-dependent activation of BK Caϩϩ channels because BK Caϩϩ channel inhibition with paxilline blocked the CP and CPϩR-induced increases in Akt pathway activation ( Figure  6 ). Although activation of Akt signaling is considered beneficial and prosurvival after ischemia-reperfusion injury, it is unclear what specific role (if any) Akt may play in modulating the acute increases in myocardial function after CPϩR treatment. Further studies will need to address whether this aspect of improved function associated with rottlerin is necessary.
Rottlerin has demonstrated antioxidant properties, although it is unclear whether these effects are due to BK Caϩϩ opening or other additional mechanisms. 10, 31 However, we did not find any evidence that rottlerin directly influences oxidantdependent damage as measured by total lysate protein and lipid oxidation. Specific investigation of these effects may be required in isolated mitochondria and with more sensitive methods. Finally, it is highly likely that the dose of rottlerin used in the present studies did not inhibit PKC␦. Previous studies demonstrated that PKC␦ inhibitory doses are significantly Ͼ1 mol/L. Numerous reports indicated that rottlerin may indirectly alter PKC␦ activation but at concentrations (ie, Ͼ10 mol/L) that lead to mitochondrial uncoupling and global reductions in ATP and subsequent kinase activity. 10, 11, 32 However, the dose of rottlerin used in the current study is considerably less than any dose that was previously shown to alter cellular ATP levels and lead to activation of AMPK. 32 In addition, we found no activation of AMPK with or without rottlerin in the CP-treated groups, indicating preservation of myocardial energy reserves (data not shown). We also found no phosphorylation of PKC␦ or potential downstream targets. Conversely, rottlerin 0.5 mol/L significantly increases BK Caϩϩ channel opening in cell and cellfree systems. 12
Limitations
Although the present model sought to faithfully reproduce injury associated with CP arrest in patients, a number of important shortcomings exist. First, we did not address injury associated with extracorporeal circulation and reperfusion injury associated with blood components. Second, the most common form of CP currently in use is cold blood crystalloid CP; thus, the effect of blood as a CP additive on our results is unclear. Future studies will need to address the potential benefit of rottlerin with a model that incorporates CP arrest and reperfusion after cardiopulmonary bypass.
Conclusions
The present study demonstrates that rottlerin, as an additive to cold crystalloid CP, improves CP-induced myocardial stun- 
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ning and vasomotor regulation likely through direct activation of BK Caϩϩ channels and not PKC␦-dependent effects. To our knowledge, this is the first use of rottlerin and a BK Caϩϩ activator in a whole-heart model of CP arrest, and we demonstrate improved cardiomyocyte and vascular function after reperfusion. These results indicate that rottlerin as a CP additive with no requisite before and after treatment may provide significant therapeutic benefit for cardiac surgery patients.
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